Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and β-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment

Japanese Journal of Cancer Research

Volumn 88, Issue 6, 1997, Pages 543-552

  Okajima, Eijiro ^a   Ozono, Seiichiro ^a   Endo, Takehiro ^a   Majima, Toshimitsu ^a   Tsutsumi, Masahiro ^a   Fukuda, Tomokazu ^a   Akai, Hiroyuki ^a   Denda, Ayumi ^a   Hirao, Yoshihiko ^a   Okajima, Eigoro ^a   Nishino, Hoyoku ^b   Nir, Zohar ^c   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c LycoRed Nat Prod Industries Ltd   (Israel)

Author keywords

BBN; Carotenoid; NSAID; Rat; Urinary bladder carcinoma

Indexed keywords

BETA CAROTENE; CAROTENOID; CYCLINE; LYCOPENE; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; EPITHELIUM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRANSITIONAL CELL CARCINOMA;

EID: 15644366465     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00417.x     Document Type: Article

References (39)

1. Kiemeney, L. A. L. M., Witjes, J. A., Heijbroek, R. P., Debruyene, F. M. J. and the Members of the Dutch South-East Urological Group: The clinical epidemiology of superficial bladder cancer. Br. J. Cancer, 67, 806-812 (1993).
2. Hirao, Y., Ozono, S., Momose, H., Okajima, E., Hiramatsu, T., Yoshida, K., Fukushima, S., Ohashi, Y. and the Members of the Nara Uro-oncology Research Group (NUORG): Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Cancer Chemother. Pharmacol., 35 (Suppl.), S36-S40 (1994).
3. Lamm, D. L., Thor, D. E., Harris, S. C., Reyna, J. A., Stogdill, V. D. and Radwin, H. M. Bacillus Calmette-Guerine immunotherapy of superficial bladder cancer. J. Urol., 124, 38-42 (1980).
4. Earnest, D. L., Hixson, L. J. and Alberts, D. S. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell. Biochem., 16 (Suppl.), 156-166 (1992).
5. Boon, C. W., Kelloff, G. J. and Malone, W. E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials. Cancer Res., 50, 2-9 (1990).
6. Reddy, B. S., Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflationary drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346 (1987).
7. Tanaka, T., Nishikawa, A., Mori, Y., Morishita, Y. and Mori, H. Inhibitory effect of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin, on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats. Cancer Lett., 48, 177-182 (1989).
8. Smith, W. L., Meade, E. A. and DeWitt, D. L. Interaction of PGH synthase isozyme-1 and -2 with NSAIDs. Ann. N. Y. Acad. Sci, 744, 50-57 (1994).
9. Noguchi, M., Earashi, M., Minami, M., Kinoshita, K. and Miyazaki, I. Effects of eicosapentaenoic acid on cell growth and prostaglandin E and leukotriene B production by a human breast cancer cell line (MDA-MB-231). Oncology, 52 ,458-464 (1995).
10. 2 and cyclooxygenase-2. Eur. J. Biochem., 226, 125-131 (1994).
11. Hubbard, W. C., Alley, M. C., McLemore, T. L. and Boyd, M. R. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. Cancer Res., 48, 4770-4775 (1988).
12. Kargmann, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A. and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2256-2559 (1995).
13. Muller-Decker, K., Scholz, K., Marks, F. and Furstenberger, G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinog., 12, 31-41 (1995).
14. Wise, R. W., Zenser, T. V., Kadlubar, F. F. and Davis, B. B. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res., 44, 1893-1897 (1984).
15. Sakata, T., Hasegawa, R., Johansson, S. L., Zenser, T. V. and Cohen, S. M. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res., 46, 3903-3906 (1986).
16. 2 and ascorbic acid synthesis in bladder carcinogenesis. Carcinogenesis, 10, 1651-1656 (1989).
17. Shibata, M., Hasegawa, R., Shirai, T., Takesada, Y. and Fukushima, S. Chernoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model. Int. J. Cancer, 55, 1011-1017 (1993).
18. Holmäng, S., Cano, M., Grenabo, K., Hedelin, H. and Johansson, S. L. Effect of indomethacin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urinary tract carcinogenesis in male F344 rats. Carcinogenesis, 16, 1493-1498 (1995).
19. Moon, R. C., Kelloff, G. J., Detrisac, C. J., Steele, V. E., Thomas, C. F. and Sigman, C. C. Chernoprevention of OH-BBN-induced bladder cancer in mice by piroxicam. Carcinogenesis, 14, 1487-1489 (1993).
20. Ziegler, R. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J. Nutr., 119, 116-122 (1988).
21. Peto, R., Doll, R., Buckley, J. D. and Sporn, M. B. Can dietary beta-carotene materially reduce human cancer rates? Nature, 290, 201-208 (1981).
22. Helzlsouer, K. J., Comstock, G. W. and Morris, J. S. Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer. Cancer Res., 49, 6144-6148 (1989).
23. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A. and Willett, W. C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst., 87, 1767-1776 (1995).
24. Shklar, G. and Schwartz, J. Tumor necrosis factor in experimental cancer regression with alpha-tocopherol, beta-carotene, canthaxanthin and algae extract. Eur. J. Cancer Clin. Oncol., 24, 839-850 (1988).
25. Zhang, L., Cooney, R. V. and Bartram, J. S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis, 12, 2109-2114 (1991).
26. Huang, D. S., Odeleye, O. E. and Watson, R. R. Inhibitory effect of canthaxanthin on in vitro growth of murine tumor cell. Cancer Lett., 65, 209-213 (1992).
27. Oshima, S., Ojima, F., Sakamoto, H., Ishiguro, Y. and Terao, J. Supplementation with carotenoids inhibits singlet oxygen-mediated oxidation of human plasma low-density lipoprotein. J. Agri. Food Chem., 44, 2306-2309 (1996).
28. Burton, G. W. Antioxidant action of carotenoids. J. Nutr., 119, 109-111 (1988).
29. Olson, J. A. Provitamin A function of carotenoids: the conversion of β-carotene into vitamin A. J. Nutr., 119, 105-108 (1989).
30. Tanaka, T., Morishita, Y., Suzuki, M., Kojima, T., Okumura, A. and Mori, H. Chemoprevention of mouse urinary bladder Carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis, 15, 15-19 (1994).
31. Moon, R. C. Comparative aspects of carotenoids and retinoids as chemopreventive agents for cancer. J. Nutr., 119, 127-134 (1989).
32. Ozono, S., Numata, I. and Oyasu, R. Irreversibility of low-grade superficial rat bladder carcinomas. Cancer Res., 44, 4260-4262 (1984).
33. Okajima, E., Tsutsumi, M., Okajima, E. and Konishi, Y. Cripto expression in human urological tumors. Cancer Lett., 111, 67-70 (1997).
34. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B. S. Chemoprevention of colon Carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472 (1995).
35. Hennekens, C. H., Burning, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., Willett, W. and Peto, R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med., 334, 1145-1149 (1996).
36. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S. and Hammar, S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 334, 1150-1155 (1996).
37. Murakoshi, M., Nishino, H., Satomi, Y., Takayasu, J., Hasegawa, T., Tokuda, H., Iwashima, A., Okuzumi, J., Okabe, H., Kitano, H. and Iwasaki, R. Potent preventive action of α-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than β-carotene. Cancer Res., 52, 6583-6587 (1992).
38. 14C]β-carotene and the presence of other carotenoids in rats and monkeys. J. Nutr., 120, 81-87 (1990).
39. 14C]lycopene in rats and monkeys. J. Nutr., 120, 1205-1213 (1990).